Clinical Trial Update: Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tau-pathology in sporadic and LRRK2 Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Michael J. Fox Foundation for Parkinson's Research | Conditions: Parkinson's Disease | Phase 2 | Status: RECRUITING